Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remdesivir in SARS-CoV-2 Patients at Mayo Hospital Lahore
NCT04871633Completed
- Sponsor
- King Edward Medical University
- Start
- Aug 2020
- Primary completion
- Nov 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of remdesivir in coronavirus disease 2019 (COVID-19), sponsored by King Edward Medical University. Started Aug 2020; status: completed.
02
Drugs
remdesivir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04871633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04871633.